MoneyWorks4Me

A decent increase of about 45.63% in the sales to Rs. 1623.52 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 1114.79 millions during the year-ago period.The Total revenue for the quarter ended June 2026 of  Rs. 256.26  millions  grew by 114.75% from Rs. 119.33 millions.Operating Profit saw a handsome growth to 416.44 millions from 245.61 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1623.52 1114.79 45.63 1623.52 1114.79 45.63 5030.59 3701.97 35.89
Other Income 6.23 3.76 65.69 6.23 3.76 65.69 28.59 19.20 48.91
PBIDT 416.44 245.61 69.55 416.44 245.61 69.55 1210.88 823.64 47.02
Interest 26.61 27.60 -3.59 26.61 27.60 -3.59 109.70 98.78 11.05
PBDT 389.83 218.01 78.81 389.83 218.01 78.81 1092.89 724.86 50.77
Depreciation 49.92 47.60 4.87 49.92 47.60 4.87 197.94 182.58 8.41
PBT 339.91 170.41 99.47 339.91 170.41 99.47 894.95 542.28 65.03
TAX 83.65 51.08 63.76 83.65 51.08 63.76 221.46 143.38 54.46
Deferred Tax -2.85 7.49 -138.05 -2.85 7.49 -138.05 -8.87 -15.89 -44.18
PAT 256.26 119.33 114.75 256.26 119.33 114.75 673.49 398.90 68.84
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 25.65 22.03 16.42 25.65 22.03 16.42 24.07 22.25 8.19
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..